Enzyme-Linked Immunosorbent Assay (ELISA) Market shall reach a value of $27,954.9 Million in 2027, growing with a CAGR of 5% during the forecast period of 2020 to 2027.

Enzyme-Linked Immunosorbent Assay (ELISA) Market Competition
Key companies operating in this industry are R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, EMD Millipore, BioLegend, LOEWE Biochemica and Shenzhen YHLO Biotech.

Coverage Highlights
• Enzyme-Linked Immunosorbent Assay (ELISA) Market Revenue Estimation and Forecast (2020 – 2027)
• Production Estimation and Forecast (2020 – 2027)
• Sales/Consumption Volume Estimation and Forecast (2020 – 2027)
• Breakdown of Revenue by Segments (2020 – 2027)
• Breakdown of Production by Segments (2020 – 2027)
• Breakdown of Sales Volume by Segments (2020 – 2027)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis

Enzyme-Linked Immunosorbent Assay (ELISA) Market Segmentation
Product Outlook (Revenue, USD Million, 2020 - 2027)
• ELISA Sets
• ELISA Kits
Application Outlook (Revenue, USD Million, 2020 - 2027)
• ELISA in HIV
• ELISA in West Nile Virus
• Detecting Antigens or Antibodies
• Biodefense

Country (Revenue, USD Million, 2020 - 2027)
• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• Middle East
• Japan
• Africa
• Rest of World

Enzyme-Linked Immunosorbent Assay (ELISA) Market Companies
• R&D Systems
• Thermo Fisher Scientific
• Ortho Clinical Diagnostics
• BD Biosciences
• ZEUS Scientific
• Bio-Rad Laboratories
• ALPCO
• Enzo Life Sciences
• BioMérieux
• EMD Millipore
• BioLegend
• LOEWE Biochemica
• Shenzhen YHLO Biotech